BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ooi K, Frizelle F, Ong E, Faragher I. Current practice in preoperative therapy and surgical management of locally advanced rectal cancer: a bi-national survey. Colorectal Dis 2012;14:814-20. [PMID: 21899709 DOI: 10.1111/j.1463-1318.2011.02813.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Fitzgerald TL, Biswas T, O’brien K, Zervos EE, Wong JH. Neoadjuvant Radiotherapy for Rectal Cancer: Adherence to Evidence-Based Guidelines in Clinical Practice. World J Surg 2013;37:639-45. [DOI: 10.1007/s00268-012-1862-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
2 Glasgow SC. Advancing Dr Wong's vision for evaluating rectal cancer. Dis Colon Rectum 2013;56:1325-6. [PMID: 24201383 DOI: 10.1097/DCR.0b013e3182a6eaa3] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
3 Willson ML, Vernooij RW, Gagliardi AR, Armstrong M, Bernhardsson S, Brouwers M, Bussières A, Fleuren M, Gali K, Huckson S, Jones S, Lewis SZ, James R, Marshall C, Mazza D. Questionnaires used to assess barriers of clinical guideline use among physicians are not comprehensive, reliable, or valid: a scoping review. Journal of Clinical Epidemiology 2017;86:25-38. [DOI: 10.1016/j.jclinepi.2016.12.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
4 Ricardo Hamilton AE, Lin AA, Young CJ. The Benefits of Colorectal Surgery Surveys in Australia and New Zealand. Ann Coloproctol 2020;36:102-11. [PMID: 32429010 DOI: 10.3393/ac.2019.09.17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Beckmann KR, Bennett A, Young GP, Roder DM. Treatment patterns among colorectal cancer patients in South Australia: a demonstration of the utility of population-based data linkage. J Eval Clin Pract 2014;20:467-77. [PMID: 24851796 DOI: 10.1111/jep.12183] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
6 Crawford A, Firtell J, Caycedo-marulanda A. How Is Rectal Cancer Managed: a Survey Exploring Current Practice Patterns in Canada. J Gastrointest Canc 2019;50:260-8. [DOI: 10.1007/s12029-018-0064-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
7 Melotti G, De Antoni E, Habr-Gama A, Minicozzi A. Management of distal rectal cancer: results from a national survey. Updates Surg 2013;65:43-52. [PMID: 23335049 DOI: 10.1007/s13304-012-0192-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Adelson P, Fusco K, Karapetis C, Wattchow D, Joshi R, Price T, Sharplin G, Roder D. Use of guideline‐recommended adjuvant therapies and survival outcomes for people with colorectal cancer at tertiary referral hospitals in South Australia. J Eval Clin Pract 2017;24:135-44. [DOI: 10.1111/jep.12757] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
9 Penninckx F. Evidence-based routine use vs selective use of neoadjuvant therapy in practice: toward personalized management of advanced rectal cancer: Editorial. Colorectal Disease 2012;14:795-6. [DOI: 10.1111/j.1463-1318.2012.03080.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]